GE HealthCare Technologies Inc. · GEHC · Next earnings

GE HealthCare Technologies Inc. reports Wednesday, Feb 3, 2027

GEHC reports before market open with consensus EPS at $1.55 and revenue at $5.92B. Last quarter: GE HealthCare raises 2026 outlook as margins expand

Reports Before market open90 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $1.55 Calendar consensus
Consensus revenue $5.92B Calendar consensus
Report date Feb 3, 2027 Wednesday, date estimated
Session Before market open 90 days away

Where GEHC left off: FY2026 Q3

Full report

GE HealthCare raises 2026 outlook as margins expand

EPS surprise +11.7% Reported $1.34 vs $1.20
Revenue surprise +3.0% Reported $5.51B vs $5.35B
Stock move +6.6% Event window
Subsequent drift 0.0% Up to 20 sessions

Raised: full-year 2026 guidance increased to approximately 4% organic revenue growth and 15.5%-15.7% EBIT margin.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Capital-equipment cycles and macroeconomic conditions could affect demand.
  • Memory-chip, oil and tariff-related costs remain sources of pressure.
  • China growth, VBP pricing and lingering PCS supplier issues require monitoring.

Questions analysts left open

  • Capital-expenditure conditions and their effect on future orders.
  • Backlog volatility, including the 1.03x book-to-bill ratio.
  • Execution of the Vercado ramp toward a $500 million FY28 run-rate.

Ask FN2 about GEHC next report

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the GEHC recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent GEHC quarters

All GEHC earnings

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.